Novel transdermal delivery formulation of the monoamine oxidase inhibitor selegiline nearing release for treatment of depression.
Thase
Michael E
ME
University of Pittsburgh Medical Center and the Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA.